A multi-item Physician Global Assessment scale to assess psoriasis disease severity: validation based on four phase III tofacitinib studies

BACKGROUND: Several different Physician Global Assessment (PGA) versions have been used in clinical studies as a co-primary end point to evaluate psoriasis severity. Tofacitinib is an oral Janus kinase inhibitor. We performed an analysis of the PGA using data from studies of tofacitinib in moderate...

Descripción completa

Detalles Bibliográficos
Autores principales: Callis Duffin, Kristina, Bushmakin, Andrew G., Cappelleri, Joseph C., Mallbris, Lotus, Mamolo, Carla
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555979/
https://www.ncbi.nlm.nih.gov/pubmed/31174539
http://dx.doi.org/10.1186/s12895-019-0088-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555979/
https://www.ncbi.nlm.nih.gov/pubmed/31174539
http://dx.doi.org/10.1186/s12895-019-0088-2

Ejemplares similares